Tam Hoang Minh1, Amine Mazine1, Ismail Bouhout1, Ismail El-Hamamsy1, Michel Carrier1, Denis Bouchard1, Philippe Demers2. 1. Department of Cardiovascular Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada. 2. Department of Cardiovascular Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada. Electronic address: philippe.demers@icm-mhi.org.
Abstract
OBJECTIVES: To review our experience with sutureless aortic valve replacement (AVR) in the setting of concomitant mitral valve (MV) surgery and discuss the technical considerations. METHODS: Between January 2012 and March 2013, 10 patients underwent sutureless AVR with the Perceval prosthesis in the setting of concomitant mitral disease. Five patients underwent MV repair, 4 underwent MV replacement, and 1 had a previously implanted mechanical mitral prosthesis. RESULTS: The median age was 79 years and 7 patients (70%) were male. Median logistic EuroSCORE II was 6.2%. All valves were successfully implanted with no 30-day mortality. There was no residual aortic paravalvular leak. Two patients had from third-degree atrioventricular block requiring permanent pacemaker implantation. At a mean follow-up of 8±4 months (range, 2-16 months), the overall survival was 80% with 2 non-valve-related deaths and the mean transaortic gradient and aortic valve area had improved to 11.1±4.6 mm Hg and 1.5±0.3 cm2, respectively. There was no evidence of mitral dysfunction in any patient. CONCLUSIONS: In our experience, sutureless AVR in the setting of concomitant mitral surgery is a feasible and reproducible procedure. Elderly patients undergoing multiple valve surgery present a higher operative risk, therefore extending the indication for sutureless AVR to patients with concomitant mitral disease could greatly benefit this specific population.
OBJECTIVES: To review our experience with sutureless aortic valve replacement (AVR) in the setting of concomitant mitral valve (MV) surgery and discuss the technical considerations. METHODS: Between January 2012 and March 2013, 10 patients underwent sutureless AVR with the Perceval prosthesis in the setting of concomitant mitral disease. Five patients underwent MV repair, 4 underwent MV replacement, and 1 had a previously implanted mechanical mitral prosthesis. RESULTS: The median age was 79 years and 7 patients (70%) were male. Median logistic EuroSCORE II was 6.2%. All valves were successfully implanted with no 30-day mortality. There was no residual aortic paravalvular leak. Two patients had from third-degree atrioventricular block requiring permanent pacemaker implantation. At a mean follow-up of 8±4 months (range, 2-16 months), the overall survival was 80% with 2 non-valve-related deaths and the mean transaortic gradient and aortic valve area had improved to 11.1±4.6 mm Hg and 1.5±0.3 cm2, respectively. There was no evidence of mitral dysfunction in any patient. CONCLUSIONS: In our experience, sutureless AVR in the setting of concomitant mitral surgery is a feasible and reproducible procedure. Elderly patients undergoing multiple valve surgery present a higher operative risk, therefore extending the indication for sutureless AVR to patients with concomitant mitral disease could greatly benefit this specific population.
Authors: Muhammet Onur Hanedan; Mehmet Ali Yuruk; Ali Ihsan Parlar; Ugur Ziyrek; Ali Kemal Arslan; Ufuk Sayar; Ilker Mataraci Journal: Tex Heart Inst J Date: 2018-02-01
Authors: Muhammet Onur Hanedan; İlker Mataracı; Mehmet Ali Yürük; Tanıl Özer; Ufuk Sayar; Ali Kemal Arslan; Uğur Ziyrek; Murat Yücel Journal: Korean J Thorac Cardiovasc Surg Date: 2016-06-05
Authors: Alina Zubarevich; Marcin Szczechowicz; Konstantin Zhigalov; Anja Osswald; Jef Van den Eynde; Arian Arjomandi Rad; Robert Vardanyan; Daniel Wendt; Bastian Schmack; Arjang Ruhparwar; Alexander Weymann Journal: J Thorac Dis Date: 2021-06 Impact factor: 2.895